Vifor Pharma AG (OTCMKTS:GNHAY – Get Rating) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 200 shares, an increase of 100.0% from the May 15th total of 100 shares. Based on an average daily volume of 100 shares, the […]
Vifor Pharma AG (OTCMKTS:GNHAF – Get Rating) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 2,900 shares, a drop of 75.2% from the May 15th total of 11,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is […]
Vifor Pharma (OTCMKTS:GNHAF – Get Rating) had its price objective lifted by analysts at UBS Group from CHF 167 to CHF 179 in a research note issued on Tuesday, The Fly reports. Shares of GNHAF opened at $173.25 on Tuesday. The business’s fifty day simple moving average is $174.60 and its two-hundred day simple moving […]
Vifor Pharma AG (OTCMKTS:GNHAF – Get Rating) was the recipient of a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 6,700 shares, a decline of 61.5% from the March 15th total of 17,400 shares. Based on an average daily volume of 100 shares, the […]